News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,124 Results
Type
Article (87541)
Company Profile (827)
Press Release (774736)
Multimedia
Podcasts (178)
Webinars (28)
Section
Business (233101)
Career Advice (4140)
Deals (39813)
Drug Delivery (140)
Drug Development (91285)
Employer Resources (203)
FDA (18299)
Job Trends (17407)
News (397496)
Policy (39931)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (130)
Alliances (56980)
ALS (147)
Alzheimer's disease (1693)
Antibody-drug conjugate (ADC) (268)
Approvals (18339)
Artificial intelligence (516)
Autoimmune disease (106)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (167)
Biotechnology (485)
Bladder cancer (139)
Brain cancer (53)
Breast cancer (530)
Cancer (4188)
Cardiovascular disease (365)
Career advice (3562)
Career pathing (38)
CAR-T (259)
CDC (57)
Cell therapy (714)
Cervical cancer (33)
Clinical research (75840)
Collaboration (1456)
Company closure (4)
Compensation (967)
Complete response letters (63)
COVID-19 (2966)
CRISPR (85)
C-suite (629)
Cystic fibrosis (142)
Data (4971)
Decentralized trials (2)
Denatured (64)
Depression (114)
Diabetes (467)
Diagnostics (7114)
Digital health (38)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (247)
Drug pricing (195)
Drug shortages (36)
Duchenne muscular dystrophy (209)
Earnings (99318)
Editorial (55)
Employer branding (25)
Employer resources (172)
Events (133563)
Executive appointments (998)
FDA (20899)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1309)
Gene editing (181)
Generative AI (52)
Gene therapy (568)
GLP-1 (1042)
Government (5394)
Grass and pollen (8)
Guidances (374)
Healthcare (20939)
HIV (49)
Huntington's disease (41)
IgA nephropathy (68)
Immunology and inflammation (257)
Immuno-oncology (22)
Indications (60)
Infectious disease (3218)
Inflammatory bowel disease (192)
Inflation Reduction Act (16)
Influenza (103)
Intellectual property (201)
Interviews (816)
IPO (17932)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (82)
Layoffs (643)
Leadership (37)
Legal (10151)
Liver cancer (92)
Longevity (13)
Lung cancer (593)
Lymphoma (287)
Machine learning (33)
Management (66)
Manufacturing (675)
MASH (147)
Medical device (14915)
Medtech (14944)
Mergers & acquisitions (22793)
Metabolic disorders (1199)
Multiple sclerosis (141)
NASH (23)
Neurodegenerative disease (239)
Neuropsychiatric disorders (63)
Neuroscience (2772)
NextGen: Class of 2025 (7707)
Non-profit (5098)
Now hiring (60)
Obesity (579)
Opinion (316)
Ovarian cancer (143)
Pain (173)
Pancreatic cancer (179)
Parkinson's disease (246)
Partnered (32)
Patents (432)
Patient recruitment (341)
Peanut (57)
People (66373)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23392)
Phase II (32906)
Phase III (24818)
Pipeline (2939)
Policy (304)
Postmarket research (3554)
Preclinical (10572)
Press Release (72)
Prostate cancer (206)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (716)
Real estate (7423)
Recruiting (79)
Regulatory (28157)
Reports (65)
Research institute (2698)
Resumes & cover letters (651)
Rett syndrome (17)
RNA editing (15)
RSV (77)
Schizophrenia (140)
Series A (215)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4320)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (112)
Vaccines (1066)
Venture capital (69)
Weight loss (409)
Women's health (62)
Worklife (21)
Date
Today (191)
Last 7 days (1084)
Last 30 days (3414)
Last 365 days (33683)
2025 (28660)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (81)
Alaska (7)
Arizona (311)
Arkansas (14)
Asia (51086)
Australia (8982)
California (9964)
Canada (2950)
China (954)
Colorado (417)
Connecticut (442)
Delaware (285)
Europe (117425)
Florida (1465)
Georgia (326)
Hawaii (3)
Idaho (67)
Illinois (830)
India (56)
Indiana (489)
Iowa (20)
Japan (339)
Kansas (127)
Kentucky (39)
Louisiana (23)
Maine (79)
Maryland (1326)
Massachusetts (7448)
Michigan (321)
Minnesota (590)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (80)
New Jersey (2750)
New Mexico (32)
New York (2678)
North Carolina (1450)
North Dakota (10)
Northern California (4599)
Ohio (310)
Oklahoma (22)
Oregon (51)
Pennsylvania (2054)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3796)
Tennessee (153)
Texas (1558)
United States (36549)
Utah (300)
Virginia (255)
Washington D.C. (84)
Washington State (846)
West Virginia (4)
Wisconsin (103)
Wyoming (2)
There are 863,124 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Novo’s Metsera Bid Attracts FTC Scrutiny As Pfizer Matches $10B Offer
Pressure from the FTC and Pfizer is building around Novo Nordisk’s bid to snatch obesity biotech Metsera: The antitrust watchdog has spotted issues with the structure of Novo’s bid, while its New York-based rival has put more money on the table.
November 6, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
November 6, 2025
·
2 min read
Press Releases
Koya Medical to Present at the Stifel 2025 Healthcare Conference in New York
November 6, 2025
·
1 min read
Press Releases
BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates
November 6, 2025
·
22 min read
Press Releases
4DMT Announces Positive Long-Term Data from Phase 1/2 PRISM Clinical Trial in Wet AMD Supporting 4D-150’s Potential as a Backbone Therapy with Consistent and Durable Benefit over Multiple Years
November 6, 2025
·
9 min read
Press Releases
Enovis Announces Third Quarter 2025 Results
November 6, 2025
·
26 min read
Press Releases
4DMT Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants
November 6, 2025
·
5 min read
Press Releases
Proxima Clinical Research Acquired, Names Industry Veteran Eric Ross as new CEO to Drive Growth in Houston MedTech Hub
November 6, 2025
·
2 min read
Press Releases
BlueWillow Biologics’ Intranasal Bird Flu Vaccine Shows Signs of Broad Immune Response in Phase I Clinical Trial Published in Nature Communications
November 6, 2025
·
3 min read
Press Releases
Interim Report Q3 2025: Solid quarter with 1% organic growth, 11% EBITA margin and DKK 410 million cash flow
November 6, 2025
·
7 min read
1 of 86,313
Next
